CSF1R and breast cancer: The depletion of M2 TAMs using CSF-1R antagonists in resected breast tissue from 179 BC patients not only promoted the functions of cytotoxic T lymphocytes (CTLs) in antitumor immunity but also increased chemosensitivity [191].